Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
Hosted on MSN
India approves Zolgensma, one of world’s costliest drugs. Why it’s sparked hope, but also concern
New Delhi: For the last three months, a mother in Ratnagiri, Maharashtra, has been desperately trying to raise funds for accessing Zolgensma—not only a global blockbuster but also a super-expensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback